The level of ALT, AST, ALP and TG was dose-dependently reduced in the low, medium, high dose of Portulaca Oleracea extract (POE-L, POE-M, POE-H, 25, 50, 100 mg/kg) group and the bifendate (BF, 3.75 mg/kg) group compared with the ALI group (p < 0.05). This evidence concerns the gene GPT and acute respiratory distress syndrome.